Poly(ADP-ribose) polymerase inhibitor-associated myelodysplastic syndrome/acute myeloid leukemia: a pharmacovigilance analysis of the FAERS database

被引:10
作者
Ma, Z. [1 ]
Sun, X. M. [2 ]
Lu, W. C. [1 ]
Zhao, Z. X. [1 ]
Xu, Z. M. [3 ]
Lyu, J. Y. [3 ]
Zhao, P. [3 ]
Liu, L. H. [1 ]
机构
[1] Capital Med Univ, Beijing Chao Yang Hosp, Dept Pharm, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Pharm, Beijing, Peoples R China
[3] AI Phoenix Technol Co Ltd, Hong Kong, Peoples R China
关键词
D O I
10.1016/j.esmoop.2020.100033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:2
相关论文
共 5 条
[1]   Targeting DNA Repair in Cancer : Beyond PARP Inhibitors [J].
Brown, Jessica S. ;
O'Carrigan, Brent ;
Jackson, Stephen P. ;
Yap, Timothy A. .
CANCER DISCOVERY, 2017, 7 (01) :20-37
[2]   Exploring and comparing adverse events between PARP inhibitors [J].
LaFargue, Christopher J. ;
Dal Molin, Graziela Z. ;
Sood, Anil K. ;
Coleman, Robert L. .
LANCET ONCOLOGY, 2019, 20 (01) :E15-E28
[3]   Therapy-related myeloid neoplasms: when genetics and environment collide [J].
McNerney, Megan E. ;
Godley, Lucy A. ;
Le Beau, Michelle M. .
NATURE REVIEWS CANCER, 2017, 17 (09) :513-527
[4]   Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era [J].
Morton, Lindsay M. ;
Dores, Graca M. ;
Schonfeld, Sara J. ;
Linet, Martha S. ;
Sigel, Byron S. ;
Lam, Clara J. K. ;
Tucker, Margaret A. ;
Curtis, Rochelle E. .
JAMA ONCOLOGY, 2019, 5 (03) :318-325
[5]   Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States [J].
Shenolikar, Rahul ;
Durden, Emily ;
Meyer, Nicole ;
Lenhart, Gregory ;
Moore, Kathleen .
GYNECOLOGIC ONCOLOGY, 2018, 151 (02) :190-195